AI Inference Platform for Drug Discovery
A quiet week.
Points come from real numbers anyone can check: new job posts, site traffic, software downloads and confirmed news. How scoring works
No points yet this week. Momentum comes from a company's job posts, site traffic and software downloads. When we have none of those numbers for a company, it scores from news only.
Facts from Y Combinator’s public list, last updated Nov 15. A free game. No real money. Points are a game score, not a judgment of what a company is worth.
Something wrong, or want this page gone? Fix or remove this page. Removal requests from a company's team are always honored. Founder of Tamarind Bio? Claim this page for a Founder-verified badge and your own pitch.
Nobody has drafted Tamarind Bio yet. Be the first.
Lets drug researchers use hundreds of computer tools to design new medicines.
If it works, scientists can spend more time on ideas and less time on setup, which could speed up finding new medicines.
Finding a new medicine starts with computer work that uses many separate programs. Small labs often cannot afford the big machines these programs need.
Scientists pick tools from one website, or let their other software use them. The work runs on rented computers, so labs skip buying expensive machines.
Biotech companies and drug research labs. They pay a fee to use the tools.
A business selling research tools to drug companies and labs. It is a busy space with many players.
Why now: Powerful AI programs that predict how molecules behave have spread widely, and labs want to use them easily.
Written by AI from the company's public site. Not checked by the company. Something wrong? Fix it.